8-K: SS&C Technologies Reports Record Q4, Full Year 2025 Results

Sentiment:

Quarterly and Annual Financial Results


SS&C Technologies Holdings, Inc. announced record adjusted revenues and EBITDA for Q4 and full year 2025, alongside strong operating cash flow and significant shareholder returns.

Better than expectedAdjusted revenue growth of 8.1% for Q4 and 6.6% for FY 2025, along with strong adjusted organic revenue growth, indicates robust business performance.Adjusted diluted EPS increased significantly by 18.2% in Q4 and 13.5% for FY 2025.Net cash generated from operating activities increased by 25.7% for the full year, demonstrating strong cash flow generation.The company returned over $1 billion to shareholders through share repurchases in 2025, signaling confidence and commitment to shareholder value.Improved adjusted consolidated EBITDA margin for the full year.

Summary

  • Q4 2025 GAAP Revenue was $1,653.5 million, an increase of 8.1% compared to Q4 2024.
  • Q4 2025 Adjusted Revenue reached a record $1,654.6 million, up 8.1% from Q4 2024.
  • Full Year 2025 GAAP Revenue was $6,272.2 million, an increase of 6.6% compared to FY 2024.
  • Full Year 2025 Adjusted Revenue was a record $6,276.2 million, up 6.6% from FY 2024.
  • Q4 2025 Adjusted Diluted Earnings Per Share (EPS) was $1.69, an increase of 18.2% from Q4 2024.
  • Full Year 2025 Adjusted Diluted EPS was $6.14, an increase of 13.5% from FY 2024.
  • Net cash generated from operating activities for the twelve months ended December 31, 2025, was $1,744.8 million, up 25.7% compared to the same period in 2024.
  • The company returned $384.2 million to shareholders in Q4 2025, including 3.7 million shares repurchased for $318.7 million and $65.5 million in common stock dividends.
  • Over $1 billion was allocated to share repurchases in 2025, purchasing 12.3 million shares at an average price of $84.12 per share.
  • Q4 2025 Adjusted Consolidated EBITDA attributable to SS&C was a record $651.0 million, up 8.7%, with a margin of 39.3%.
  • Full Year 2025 Adjusted Consolidated EBITDA margin was 39.2%, an increase of 40 basis points compared to FY 2024.
  • Q4 2025 GAAP Diluted EPS was $0.77, a decrease of 21.4% from Q4 2024.
  • Q4 2025 GAAP Net Income attributable to SS&C was $193.1 million, down 22.2% from Q4 2024.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a strong performance, with record adjusted revenues and EBITDA, significant cash flow generation, and substantial shareholder returns, despite a decline in GAAP EPS primarily due to non-operating factors.

Positives

  • Record adjusted revenues of $1,654.6 million for Q4 2025 and $6,276.2 million for FY 2025, both up 8.1% and 6.6% respectively.
  • Record adjusted consolidated EBITDA of $651.0 million for Q4 2025, up 8.7%.
  • Strong adjusted organic revenue growth of 5.3% for Q4 2025 and 4.8% for FY 2025.
  • Net cash generated from operating activities increased by 25.7% to $1,744.8 million for FY 2025.
  • Operating cash flow per weighted average diluted shares outstanding increased to $6.89 in 2025 from $5.47 in 2024.
  • Significant shareholder returns, including $384.2 million in Q4 2025 (3.7 million shares repurchased for $318.7 million and $65.5 million in dividends).
  • Over $1 billion allocated to share repurchases in 2025, acquiring 12.3 million shares at an average price of $84.12.
  • Adjusted diluted earnings per share increased by 18.2% to $1.69 for Q4 2025 and 13.5% to $6.14 for FY 2025.
  • Consolidated net leverage ratio improved to 2.80 times consolidated EBITDA.
  • Adjusted consolidated EBITDA margin for FY 2025 improved by 40 basis points to 39.2%.
  • Alternative Assets Under Administration increased by $637 billion over two years.

Negatives

  • GAAP Diluted Earnings Per Share for Q4 2025 decreased by 21.4% to $0.77.
  • GAAP Net Income attributable to SS&C for Q4 2025 decreased by 22.2% to $193.1 million.
  • GAAP operating income margin for Q4 2025 decreased by 110 basis points to 22.3%.
  • Intelligent Automation & Analytics business segment experienced a -7.0% organic revenue growth in Q4 2025 and only 0.1% for FY 2025.
  • Healthcare business segment experienced a -14.0% organic revenue growth in Q4 2025 and -3.3% for FY 2025.
  • Intralinks business segment experienced -4.5% and -2.8% organic revenue growth in Q2 and Q3 2025 respectively, resulting in a -0.3% for FY 2025.

Risks

  • The state of the economy and the financial services industry and other industries in which the Company's clients operate.
  • The Company's ability to realize anticipated benefits from its acquisitions.
  • The effect of customer consolidation on demand for the Company's products and services.
  • The variability of revenue as a result of activity in the securities markets.
  • The focus of the Company's business on the asset management industry.
  • The ability to retain and attract clients.
  • The intensity of competition with respect to the Company's products and services.
  • Risks from cyber-attacks, breaches of digital security, IT system failures and network disruptions.
  • Risks associated with third party providers.
  • Fluctuations in the Company's operating results.
  • Terrorist activities and other catastrophic events.
  • Risks associated with the Company's foreign operations.
  • Privacy concerns relating to the collection and storage of personal information.
  • Evolving regulations and increased scrutiny from regulators.
  • The Company's ability to protect intellectual property assets and litigation regarding intellectual property rights.
  • Delays in product development.
  • Investment decisions concerning cash balances.
  • Tax risks.
  • Risks associated with the Company's joint ventures.
  • Changes in accounting standards.
  • The Company's exposure to litigation and other claims.
  • Risks related to the Company's substantial indebtedness.
  • The market price of the Company's stock prevailing from time to time.

Future Outlook

SS&C Technologies projects Q1 2026 adjusted revenues between $1,608 million and $1,648 million, and full-year 2026 adjusted revenues between $6,654 million and $6,814 million. Adjusted diluted EPS for FY 2026 is guided to be $6.70 to $7.02, with cash from operating activities expected to be between $1,713 million and $1,813 million. The company anticipates a midpoint organic growth rate of 5.0% for Q1 2026 and 5.1% for FY 2026.

Management Comments

  • "SS&C's 2025 performance reflects exceptional execution and the depth and breadth of our product and service portfolio."
  • "This quarter, we delivered record adjusted revenues of $1,655 million and adjusted consolidated EBITDA of $651 million, setting us up for a strong 2026."
  • "AI advancements are rapidly reshaping the vertical software landscape. Our deep expertise and proprietary technology create a unique, deep and wide moat. This protective moat gives us time and perspective to leverage these innovations to drive long-term value."

Industry Context

StockSavvy.ai notes that SS&C Technologies operates in the highly competitive and evolving financial services and healthcare software industries. The company's emphasis on "AI advancements" and its "deep and wide moat" suggests a strategic focus on leveraging emerging technologies to maintain its market position against competitors like BlackRock Solutions (Aladdin), FIS, and Broadridge, which also offer comprehensive financial technology solutions. The strong organic revenue growth in core segments like GlobeOp and GIDS indicates robust demand for its specialized services, while challenges in Intelligent Automation & Analytics and Healthcare suggest areas requiring strategic re-evaluation in a dynamic market.

Comparison to Industry Standards

  • SS&C's Q4 2025 adjusted revenue growth of 8.1% and full-year 2025 adjusted revenue growth of 6.6% are competitive within the financial technology sector, which often sees growth rates varying based on market conditions and M&A activity. For instance, major competitors like FIS and Broadridge typically report revenue growth in the mid-to-high single digits, with some variations depending on specific business segments.
  • The adjusted consolidated EBITDA margin of 39.3% for Q4 2025 and 39.2% for FY 2025 demonstrates strong operational efficiency, generally exceeding the average for many software and services companies, which often range from 25-35%. This indicates effective cost management and pricing power.
  • The 25.7% increase in net cash from operating activities to $1,744.8 million for FY 2025 is a robust performance, reflecting strong cash generation capabilities. This level of cash flow generation is critical for debt reduction and shareholder returns, positioning SS&C favorably compared to peers with higher capital expenditure requirements or lower operating margins.
  • The net leverage ratio of 2.80x is a healthy level for a company of SS&C's size and acquisition history, indicating prudent debt management. Many industry peers aim for similar or lower leverage ratios to maintain financial flexibility.

Stakeholder Impact

  • Shareholders: Positive impact due to significant share repurchases ($1 billion in 2025) and common stock dividends ($65.5 million in Q4 2025), indicating management's commitment to returning capital. Strong adjusted financial performance and positive future outlook could lead to increased share value.
  • Employees: The company's continued growth and strategic focus on technology (AI) may imply stability and potential for innovation-driven roles, though "facilities and workforce restructuring" costs suggest ongoing operational adjustments.
  • Customers: Continued investment in proprietary technology and services, as highlighted by management, aims to enhance product offerings and service quality, benefiting clients in financial services and healthcare.
  • Creditors: Improved net leverage ratio (2.80x) and strong operating cash flow enhance the company's ability to service its substantial indebtedness, reducing credit risk.

Next Steps

  • Q1 2026 earnings call to discuss Q1 2026 results and updated guidance.
  • Continue leveraging AI innovations to drive long-term value.
  • Ongoing capital allocation strategy including debt paydown, share repurchases, dividends, and strategic investments.

Key Dates

DateDescription
1986SS&C Technologies founded.
April 2018Date of the Company's Credit Agreement.
2021Company entered into a joint venture named DomaniRx, LLC.
December 31, 2024End of prior fiscal year and fourth quarter.
July 2025Tax bill signed which positively impacted effective tax rate.
December 31, 2025End of current fiscal year and fourth quarter.
February 5, 2026Date of report and announcement of financial results for Q4 and FY 2025.

Recommendation

strong buy

The company delivered record adjusted revenues and EBITDA, demonstrating robust underlying business performance and effective operational management. The significant increase in operating cash flow and substantial capital returns to shareholders through buybacks and dividends highlight strong financial health and a commitment to shareholder value. While GAAP EPS declined, this appears to be driven by non-operating adjustments, and the adjusted metrics, which management uses to evaluate performance, show strong growth. The positive guidance for FY 2026, coupled with a healthy leverage ratio and strategic focus on AI, positions SS&C for continued growth and makes it an attractive investment.

Keywords

SS&C Technologies, SSNC, Financial Results, Q4 2025, Full Year 2025, Earnings, Software-enabled services, Investment software, Healthcare software, Adjusted Revenue, Adjusted EBITDA, EPS, Share Repurchase, Dividends, Operating Cash Flow, Financial Technology, FinTech, Wealth Management, Asset Management, AI advancements

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.